Quantcast
Last updated on April 21, 2014 at 11:58 EDT

Latest Ulcerative colitis Stories

2011-05-18 00:01:30

The Crohn's & Colitis Foundation of America is hosting a live webinar for caregivers, pediatric healthcare professionals, and children and teens with Crohn's disease to address critical issues about managing and coping with disease. New York, NY (PRWEB) May 17, 2011 WHO: This live and interactive webinar will be of interest to children and teens with Crohn's disease, their caregivers, and healthcare professionals. WHAT: The Crohn's & Colitis Foundation of America is hosting an...

2011-05-10 08:00:00

ABBOTT PARK, Ill., May 10, 2011 /PRNewswire/ -- Abbott's (NYSE: ABT) HUMIRA® (adalimumab) met its primary endpoint of clinical remission in a Phase III study of adult patients with moderate to severe ulcerative colitis. Results were presented at the Digestive Disease Week (DDW) scientific conference in Chicago. Ulcerative colitis (UC) is a chronic autoimmune disease that causes inflammation and ulceration in the lining of the colon or large intestine. It is estimated...

2011-05-09 15:30:00

CHICAGO, May 9, 2011 /PRNewswire/ -- Data from a Phase 3 randomized, multicenter, open-label study demonstrated clinical response with REMICADE® (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC), and showed a safety profile consistent with previous clinical trials conducted in an adult population. The pediatric UC findings, presented today at Digestive Disease Week, showed REMICADE induced clinical response in...

2011-05-05 00:00:31

The Philadelphia/Delaware Valley Chapter of the Crohn's & Colitis Foundation of America (CCFA) will host a Take Steps for Crohn's & Colitis Walk on May 21, 2011 at the Philadelphia Art Museum. Philadelphia, PA (PRWEB) May 04, 2011 On May 21, 2011 at the Philadelphia Art Museum, the Philadelphia/Delaware Valley Chapter of the Crohn's & Colitis Foundation of America (CCFA) will host Take Steps for Crohn's & Colitis Walk, the nation's largest annual walk dedicated to finding...

2011-04-25 08:16:34

(Ivanhoe Newswire) -- Patients with inflammatory bowel disease (IBD) have a greater risk of dying if they become infected with Clostridium difficile, according to a new study. IBD, which includes Crohn's disease and ulcerative colitis, causes symptoms such as abdominal pain and diarrhea. Patients with the condition are often sent to the hospital when they experience severe symptoms. The C. difficile infection is not usually fatal in people who are not already severely ill or elderly. British...

2011-04-20 13:14:56

Patients admitted to hospital with inflammatory bowel disease face a sixfold greater risk of death if they become infected with Clostridium difficile, a new study has found Patients admitted to hospital with inflammatory bowel disease (IBD) face a sixfold greater risk of death if they become infected with Clostridium difficile, a new study has found. The researchers say IBD patients should be screened on admission to protect them from serious illness. IBD, consisting of Crohn's disease and...

2011-04-15 11:30:00

NEW YORK, April 15, 2011 /PRNewswire/ -- Mike McCready, guitarist and founding member of the American rock band, Pearl Jam, recently donated his time to create a radio public service announcement (PSA) series on behalf of the Crohn's & Colitis Foundation to raise critical awareness for Crohn's disease and ulcerative colitis. The 60, 30, and 15 second PSAs will encourage Americans to register for one of over 130 Take Steps Walks in 2011 in communities around the country. Walkers will...

2011-04-12 00:00:28

K'NEX will donate 10% of online sales to The Crohn's & Colitis Foundation during the month of April Hatfield, PA (Vocus/PRWEB) April 11, 2011 The Crohn's & Colitis Foundation of America (CCFA), a non-profit, volunteer-driven organization dedicated to finding the cure for Crohn's disease and ulcerative colitis, and K'NEX, the US construction toy company focused on Building Worlds Kids Loveâ“ž¢, are proud to announce that for the third year they will...

2011-04-08 21:47:00

ATLANTIC CITY, N.J., April 8, 2011 /PRNewswire/ -- Hagens Berman LLP, a nationally recognized law firm today praised a jury's verdict that ordered pharmaceutical company Roche (ROG:VX) to pay $2 million to a woman who suffered serious gastrointestinal damage caused by the drug Accutane, while denying similar claims of actor James Marshall and another plaintiff. (Logo: http://photos.prnewswire.com/prnh/20080317/AQM144LOGO) Accutane, along with its active ingredient, isotretinoin, was...

2011-04-08 13:54:04

Causes of IBD explored including 'hygiene hypothesis' The American College of Gastroenterology published a new evidence-based systematic review on the management of Inflammatory Bowel Disease (IBD) as a supplement to The American Journal of Gastroenterology (AJG) for April 2011, a special issue entirely dedicated to IBD. This clinical monograph, based on a comprehensive meta-analysis, offers new graded recommendations on medical management of IBD, a chronic digestive disorder which includes...